Actively Recruiting

All Genders
NCT04746066

Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19

Led by Società Italiana Talassemie ed Emoglobinopatie · Updated on 2022-05-05

10000

Participants Needed

2

Research Sites

556 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The COVID-19 pandemic is causing many deaths around the world, putting a strain on health services. Patients with pre-existing chronic conditions are most affected by the SARS-COV2 infection. Infectious complications are a common cause of mortality and one of the main causes of morbidity in all these diseases. The main objective of this project is the assessment of patients with thalassemia, drepanocytosis, other haemoglobinopathies and rares inherited anemias suffering from SARS-COV-2 to: 1. Obtain clinical and epidemiological data that can provide information on a possible increased vulnerability of these patients to SARS-COV-2 infection; 2. Sharing therapeutic approaches considering the lack of information about the treatment.

CONDITIONS

Official Title

Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with an established diagnosis of thalassemia, sickle cell disease, other hemoglobinopathies, or rare inherited anemia
  • Confirmed virological diagnosis of SARS-COV-2 infection
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

E.O. Ospedali Galliera

Genova, Italy, 16128

Actively Recruiting

2

Ospedali Galliera - S.S.D. Microcitemia, anemie congenite e dismetabolismo del ferro

Genova, Italy, 16128

Actively Recruiting

Loading map...

Research Team

G

Gian Luca Forni

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here